208 related articles for article (PubMed ID: 27432668)
1. Positron emission tomography: ligand imaging.
Moghbel M; Newberg A; Alavi A
Handb Clin Neurol; 2016; 135():229-240. PubMed ID: 27432668
[TBL] [Abstract][Full Text] [Related]
2. Neuronuclear assessment of patients with epilepsy.
Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
[TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyglucose PET in Neurology and Psychiatry.
Schöll M; Damián A; Engler H
PET Clin; 2014 Oct; 9(4):371-90, v. PubMed ID: 26050943
[TBL] [Abstract][Full Text] [Related]
4. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B; Halldin C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
[TBL] [Abstract][Full Text] [Related]
5. Pitfalls and Limitations of PET/CT in Brain Imaging.
Salmon E; Bernard Ir C; Hustinx R
Semin Nucl Med; 2015 Nov; 45(6):541-51. PubMed ID: 26522395
[TBL] [Abstract][Full Text] [Related]
6. An overview of PET neuroimaging.
Nasrallah I; Dubroff J
Semin Nucl Med; 2013 Nov; 43(6):449-61. PubMed ID: 24094712
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
8. Positron Emission Tomography.
Lameka K; Farwell MD; Ichise M
Handb Clin Neurol; 2016; 135():209-227. PubMed ID: 27432667
[TBL] [Abstract][Full Text] [Related]
9. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
[TBL] [Abstract][Full Text] [Related]
10. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
11. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
12. A perspective on the future role of brain pet imaging in exercise science.
Boecker H; Drzezga A
Neuroimage; 2016 May; 131():73-80. PubMed ID: 26477649
[TBL] [Abstract][Full Text] [Related]
13. PET tracer technology for monitoring focal epilepsies.
Koepp MJ
Expert Rev Med Devices; 2007 Mar; 4(2):191-200. PubMed ID: 17359224
[TBL] [Abstract][Full Text] [Related]
14. PET Imaging in Psychoneuroimmunology Research.
Hannestad J
Methods Mol Biol; 2018; 1781():287-307. PubMed ID: 29705853
[TBL] [Abstract][Full Text] [Related]
15. Changes in regional brain glucose metabolism measured with F-18-FDG-PET in essential tremor.
Ha SW; Yang YS; Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2015 Apr; 56(4):482-6. PubMed ID: 24782572
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
18. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
19. Efficiency gains in tracer identification for nuclear imaging: can in vivo LC-MS/MS evaluation of small molecules screen for successful PET tracers?
Joshi EM; Need A; Schaus J; Chen Z; Benesh D; Mitch C; Morton S; Raub TJ; Phebus L; Barth V
ACS Chem Neurosci; 2014 Dec; 5(12):1154-63. PubMed ID: 25247893
[TBL] [Abstract][Full Text] [Related]
20. Whiskers area as extracerebral reference tissue for quantification of rat brain metabolism using (18)F-FDG PET: application to focal cerebral ischemia.
Backes H; Walberer M; Endepols H; Neumaier B; Graf R; Wienhard K; Mies G
J Nucl Med; 2011 Aug; 52(8):1252-60. PubMed ID: 21764786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
